Uploaded February 2023 | Updated September 2026, 1 week ago
From its founding in 2014 at the Emerging Technology Centers on Johns Hopkins campus, to the launch of its target discovery and drug design platform, to its global expansion into a leading generative AI-driven biotech company advancing AI-designed drugs into human clinical trials, Insilico Medicine has had an extraordinary journey.
Anyone interested in being part of drug discovery history and telling Insilico Medicine's story should check out our documentary hackathon, Docuthon, happening now! insilico.com/docuthon
From its founding in 2014 at the Emerging Technology Centers on Johns Hopkins campus, to the launch of its target discovery and drug design platform, to its global expansion into a leading generative AI-driven biotech company advancing AI-designed drugs into human clinical trials, Insilico Medicine has had an extraordinary journey.
Anyone interested in being part of drug discovery history and telling Insilico Medicine's story should check out our documentary hackathon, Docuthon, happening now! insilico.com/docuthon
![[ARDD 2024 Recap] Preserving Muscle Mass for Healthy Aging: Old Tricks and New Targets](https://i.ytimg.com/vi/tEdu00VTdK4/mqdefault.jpg "[ARDD 2024 Recap] Preserving Muscle Mass for Healthy Aging: Old Tricks and New Targets
Lykke Sylow
Dept. Biomedical Sciences
University of Copenhagen")
